首页 › 基金 › China Universal Asset Management Co., Ltd. › ALNY
China Universal Asset Management Co., Ltd. 对 ALNY 的持仓历史
ALNYLAM PHARMACEUTICALS INC · 医疗保健
China Universal Asset Management Co., Ltd. 在 Q2 2026 的 13F 申报中披露持有 ALNY(ALNYLAM PHARMACEUTICALS INC)25,269 股,市值约 US$7.6M,约占其申报组合的 0.45%,在其申报持仓中市值排名第 47 位。 China Universal Asset Management Co., Ltd. 最近 12 个申报季度中有 12 个季度披露了 ALNY 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
China Universal Asset Management Co., Ltd. 对 ALNY 的持仓演变
China Universal Asset Management Co., Ltd. 于 Q3 2023 首次披露 ALNY 持仓:3,580 股(约 US$634K)。 该持仓在 Q3 2025 达到峰值 22,787 股,市值约 US$10.4M。 在 12 次申报中,China Universal Asset Management Co., Ltd. 6 次增持、5 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 25,269 股、市值约 US$7.6M,环比减持 -1,997 股。。 持仓曾出现大幅变动:Q4 2023 增持约 631% (随后一个季度股价下跌 22%)、Q1 2024 增持约 37% (随后一个季度股价上涨 63%)、Q3 2024 增持约 37% (随后一个季度股价下跌 14%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 3.58K | $634.02K | 新进 |
| Q4 2023 | 26.16K | $5.01M | 增持 |
| Q1 2024 | 35.82K | $5.35M | 增持 |
| Q2 2024 | 26.51K | $6.44M | 减持 |
| Q3 2024 | 36.34K | $9.99M | 增持 |
| Q4 2024 | 39.00K | $9.18M | 增持 |
| Q1 2025 | 30.97K | $8.36M | 减持 |
| Q2 2025 | 27.82K | $9.07M | 减持 |
| Q3 2025 | 22.79K | $10.39M | 减持 |
| Q4 2025 | 25.27K | $10.05M | 增持 |
| Q1 2026 | 27.27K | $9.02M | 增持 |
| Q2 2026 | 25.27K | $7.61M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ALNY 与 13F 数据
ALNY(ALNYLAM PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 ALNY,申报仓位最大的包括:T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford (US$734.5M), Orbis Allan Gray Ltd (US$598.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ALNY 的基金
- T. Rowe Price Investment Management, Inc. 5.64M 股 · $1.70B · Q2 2026
- Baillie Gifford 2.44M 股 · $734.48M · Q2 2026
- Orbis Allan Gray Ltd 1.99M 股 · $598.27M · Q2 2026
- 双西格玛投资 1.88M 股 · $564.71M · Q2 2026
- AMERICAN CENTURY COMPANIES INC 1.85M 股 · $558.10M · Q2 2026
- TWO SIGMA ADVISERS, LP 1.13M 股 · $450.36M · Q4 2025
- Deep Track Capital, LP 825.00K 股 · $248.35M · Q2 2026
- Qube Research & Technologies Ltd 798.72K 股 · $240.44M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 729.63K 股 · $219.64M · Q2 2026
- LOOMIS SAYLES & CO L P 580.19K 股 · $174.65M · Q2 2026
更多关于 China Universal Asset Management Co., Ltd.
常见问题
How long has China Universal Asset Management Co., Ltd. held ALNY?
China Universal Asset Management Co., Ltd. has disclosed ALNY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is China Universal Asset Management Co., Ltd.'s current position in ALNY?
As of Q2 2026, China Universal Asset Management Co., Ltd. holds 25.27K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $7.61M, representing 0.45% of its reported portfolio and ranking #47.
Has China Universal Asset Management Co., Ltd. been buying or selling ALNY?
In the latest 13F filing (Q2 2026), China Universal Asset Management Co., Ltd. reduced its position in ALNY. The position peaked in Q3 2025 at 22.79K shares.
Which other funds hold ALNY?
Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford, Orbis Allan Gray Ltd, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.